| Prevalence of hepatitis E virus viremia and antibodies among healthy blood donors in India H Katiyar, A Goel, A Sonker, V Yadav, S Sapun, R Chaudhary, ... Indian journal of gastroenterology 37, 342-346, 2018 | 25 | 2018 |
| Prevalence of hepatitis E viraemia among blood donors: a systematic review A Goel, HJ Vijay, H Katiyar, R Aggarwal Vox Sanguinis 115 (3), 120-132, 2020 | 23 | 2020 |
| Temporal profile of HEV RNA concentration in blood and stool from patients with acute uncomplicated hepatitis E in a region with genotype 1 predominance A Goel, K V Padmaprakash, M Benjamin, H Katiyar, R Aggarwal Journal of Viral Hepatitis 27 (6), 631-637, 2020 | 8 | 2020 |
| Genotyping of hepatitis B virus isolates from Lahaul and Spiti district in Himachal Pradesh, India B Sharma, H Katiyar, D Barall, N Sharma, S Agnihotry, A Goel, ... Indian Journal of Gastroenterology 37, 261-265, 2018 | 8 | 2018 |
| Serological Immune Response Following ChAdOx1 nCoV-19 Vaccine (Covishield®) in Patients with Liver Cirrhosis A Goel, A Verma, P Tiwari, H Katiyar, A Aggarwal, D Khetan, Mayank, ... Vaccines 10 (11), 1837, 2022 | 6 | 2022 |
| Antibody response to ChAdOx1 nCoV-19 (AZD1222) vaccine in kidney transplant recipients DS Bhadauria, H Katiyar, A Goel, P Tiwari, RVK Kishore, A Aggarwal, ... Vaccines 10 (10), 1693, 2022 | 6 | 2022 |
| Serum bile acid levels in women with intrahepatic cholestasis of pregnancy in India S Yadav, A Goel, R Lingaiah, M Pradhan, H Katiyar, R Aggarwal Journal of Clinical and Experimental Hepatology 12 (2), 379-383, 2022 | 5 | 2022 |
| Durability of ChAdOx1 nCoV-19 (Covishield®) Vaccine Induced Antibody Response in Health Care Workers A Verma, A Goel, H Katiyar, P Tiwari, A Sana, D Khetan, DS Bhadauria, ... Vaccines 11 (1), 84, 2022 | 4 | 2022 |
| Use of sofosbuvir/velpatasvir/voxilaprevir for sofosbuvir nonresponder genotype 3 HCV infection in India P Tiwari, H Katiyar, P Rai, A Goel Journal of Clinical and Experimental Hepatology 12 (2), 669-671, 2022 | 3 | 2022 |
| Blood transfusion is unlikely to be a source for hepatitis E virus transmission in India VJ Halkurike, A Goel, H Katiyar, SK Agarwal, S Pande, R Aggarwal Indian Journal of Gastroenterology 39, 161-164, 2020 | 3 | 2020 |
| Eight versus twelve weeks of sofosbuvir-velpatasvir in treatment-naïve non-cirrhotic patients with chronic hepatitis C virus infection: Study protocol for a multicentric, open … A Awasthi, H Katiyar, S Rungta, A Deep, V Kumar, Shalimar, A Kumar, ... Plos one 18 (5), e0285725, 2023 | 2 | 2023 |
| Humoral and cellular immune response in patients of liver cirrhosis and immunocompetent recipient of ChAdOx1nCoV-19 Vaccine (Covishield) H Dandu, A Goel, M Kumar, HS Malhotra, H Katiyar, M Agarwal, N Kumar, ... Clinical and Experimental Medicine 24 (1), 24, 2024 | 1 | 2024 |
| Hepatitis C retreatment with first-line direct acting antiviral drugs A Goel, H Katiyar, P Tiwari, S Rungta, A Verma, A Deep, A Sana, P Rai, ... Journal of Clinical and Experimental Hepatology 13 (5), 736-741, 2023 | 1 | 2023 |
| Rescue use of pegylated interferon in dialysis patient who failed to respond sofosbuvir H Katiyar, P Tiwari, DS Bhadauria, P Rai, A Goel Indian Journal of Nephrology 33 (2), 152-154, 2023 | 1 | 2023 |
| Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus Retreatment in Difficult-to-treat Patients: A Real-life Observational Study from India H Katiyar, M Kamat, AK Mandot, A Goel, S Singh, AK Mishra, R Singh, ... Journal of Clinical and Experimental Hepatology 14 (2), 101314, 2024 | | 2024 |
| Antibody response to ChAdOx1 nCoV‐19 (Covishield®) vaccine in people on maintenance hemodialysis DS Bhadauria, P Tiwari, A Goel, H Katiyar, A Kaul, Mayank, A Aggarwal, ... Seminars in Dialysis 36 (6), 477-482, 2023 | | 2023 |
| DETECTION AND COMPARISON OF MEMORY T CELL RESPONSE IN PATIENTS WITH LIVER CIRRHOSIS AND HEALTHY HEATH CARE WORKERS AGAINST CHADOX1NCOV-19 VACCINE (COVISHIELD) G Yadav, H Dandu, M Kumar, A Goel, H Katiyar, HS Malhotra, B Puri INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY 45, 130-130, 2023 | | 2023 |
| Memory T-cell targeted immune response in patients of liver cirrhosis and immunocompetent recipient of ChAdOx1nCoV-19 Vaccine (Covishield)” G Yadav, D Reddy, A Goel, M Kumar, H Malhotra, H Katiyar, M Agarwal, ... Authorea Preprints, 2023 | | 2023 |
| Sofosbuvir/Velpatasvir/Voxilaprevir for HCV Retreatment In Difficult To Treat Patients Who Failed With First-Line Direct Acting Antivirals: A Real-Life Data From India H Katiyar, M Kamat, A kumar Mandot, A Goel, S Singh, AK Mishra, ... Journal of Clinical and Experimental Hepatology 13, S93-S94, 2023 | | 2023 |
| Blood transfusion and surgery as a screening tool screening for HCV infection in the Indian population R Singh, AK Mishra, S Singh, H Katiyar, S Sapun, A Goel, P Rai, ... Journal of Clinical and Experimental Hepatology 13, S88, 2023 | | 2023 |
